ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,944Medicare Part D Prescriptions Filled, Including Refills

Rank: 158 out of 1383

$864K Total Retail Price of All Prescriptions

Rank: 88 out of 1383

557 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
82% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 557 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 557 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 11,309 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
HYDROCODONE-ACETAMINOPHEN 701 609 S3 1 1
GABAPENTIN 552 439 2 11
LEVOTHYROXINE SODIUM 457 378 3 4
SERTRALINE HCL 429 360 4 21
PRAVASTATIN SODIUM 413 343 5 14
WARFARIN SODIUM 405 337 6 13
CARVEDILOL 378 327 7 24
LISINOPRIL 328 253 8 3
FUROSEMIDE 322 275 9 7
LANTUS 272 242 10 50
NAMENDA 267 266 11 49
POTASSIUM CHLORIDE 222 187 12 12
OMEPRAZOLE 211 170 13 5
CARBIDOPA-LEVODOPA 207 188 14 108
DIVALPROEX SODIUM 202 151 15 78
METOPROLOL TARTRATE 192 151 16 9
DONEPEZIL HCL 186 184 17 35
LACTULOSE 153 111 18 128
RANITIDINE HCL 145 125 19 19
RISPERIDONE 144 105 20 71
EXELON 144 126 20 117
TRAZODONE HCL 142 119 22 36
NOVOLOG 137 119 23 139
CEFTRIAXONE 135 115 24 175
AMLODIPINE BESYLATE 135 131 24 6
MIRTAZAPINE 132 118 26 51
METFORMIN HCL 131 105 27 8
CITALOPRAM HBR 128 96 28 15
PANTOPRAZOLE SODIUM 125 114 29 32
CLOPIDOGREL 120 101 30 28
LEVOFLOXACIN 117 108 31 88
BENAZEPRIL HCL 106 98 32 38
PERMETHRIN 105 93 33 342
POLYETHYLENE GLYCOL 3350 103 91 34 64
MORPHINE SULFATE 100 93 S2 35 222
ATORVASTATIN CALCIUM 94 65 36 18
FENTANYL 92 53 S2 37 92
KLOR-CON M20 92 84 37 100
IPRATROPIUM-ALBUTEROL 89 71 39 138
TEKTURNA 88 88 40 287
TAMSULOSIN HCL 85 77 41 30
ZOLPIDEM TARTRATE 85 68 41 17
LIDOCAINE HCL 85 70 41 219
STROMECTOL 81 73 44 394
ADVAIR DISKUS 80 71 45 63
CLONIDINE HCL 78 50 46 44
PROMETHAZINE HCL 78 57 R 46 56
NEXIUM 76 42 48 26
CRESTOR 75 53 49 34
CEPHALEXIN 72 68 50 87
ALLOPURINOL 71 67 51 33
HYDROCHLOROTHIAZIDE 68 66 52 10
PREDNISONE 68 46 52 40
PLAVIX 67 57 54 43
GLIMEPIRIDE 65 50 55 31
FENOFIBRATE 63 42 56 65
VENLAFAXINE HCL ER 59 49 57 102
METFORMIN HCL ER 57 31 58 47
INSULIN SYRINGE 56 18 59 83
ATENOLOL 55 53 60 16
ZIPRASIDONE HCL 54 42 61 232
SPIRIVA 54 47 61 45
NITROGLYCERIN PATCH 53 41 63 177
OXYCODONE HCL-ACETAMINOPHEN 52 45 S2 64 81
DIGOXIN 51 51 65 59
GEODON 50 44 66 301
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.